Literature DB >> 23319138

Access to opioid analgesics and pain relief for patients with cancer.

Shalini Dalal1, Eduardo Bruera.   

Abstract

Access to pain relief is a crucial concern for patients with cancer, and remains so at all stages of the illness trajectory. This Review covers the scope of the problem and considers the optimal palliative strategy, mainly through the use of opioids. It also discusses various barriers to effective pain management around the world, including regulatory and attitudinal barriers towards opioids, and the unwillingness of national governments to integrate palliative care effectively in cancer control efforts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319138     DOI: 10.1038/nrclinonc.2012.237

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  73 in total

Review 1.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

2.  Italy reforms national policy for cancer pain relief and opioids.

Authors:  C Blengini; D E Joranson; K M Ryan
Journal:  Eur J Cancer Care (Engl)       Date:  2003-03       Impact factor: 2.520

Review 3.  Palliative care: a public health priority in developing countries.

Authors:  Ruth Webster; Judith Lacey; Susan Quine
Journal:  J Public Health Policy       Date:  2007       Impact factor: 2.222

4.  Desire for hastened death, cancer pain and depression: report of a longitudinal observational study.

Authors:  Sean O'Mahony; Joseph Goulet; Alice Kornblith; Geraldine Abbatiello; Bernadette Clarke; Sarah Kless-Siegel; William Breitbart; Richard Payne
Journal:  J Pain Symptom Manage       Date:  2005-05       Impact factor: 3.612

Review 5.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

6.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

7.  Cancer specialists' palliative care referral practices and perceptions: results of a national survey.

Authors:  C E Johnson; A Girgis; C L Paul; D C Currow
Journal:  Palliat Med       Date:  2008-01       Impact factor: 4.762

8.  The multidimensional nature of cancer-related pain.

Authors:  T A Ahles; E B Blanchard; J C Ruckdeschel
Journal:  Pain       Date:  1983-11       Impact factor: 6.961

9.  Pain as an early symptom in cancer.

Authors:  E Vuorinen
Journal:  Clin J Pain       Date:  1993-12       Impact factor: 3.442

10.  Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group.

Authors:  G Apolone; O Corli; A Caraceni; E Negri; S Deandrea; M Montanari; M T Greco
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

View more
  13 in total

Review 1.  Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis.

Authors:  B Afsharimani; C W Doornebal; P J Cabot; M W Hollmann; M-O Parat
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

2.  Framing of the opioid problem in cancer pain management in Canada.

Authors:  R Asthana; S Goodall; J Lau; C Zimmermann; P L Diaz; A B Wan; E Chow; C De Angelis
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

3.  Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice.

Authors:  Hiroki Wakabayashi; Satoshi Wakisaka; Toru Hiraga; Kenji Hata; Riko Nishimura; Makoto Tominaga; Toshiyuki Yoneda
Journal:  J Bone Miner Metab       Date:  2017-05-17       Impact factor: 2.626

4.  Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies.

Authors:  Dylan Zylla; Grant Steele; Alice Shapiro; Sara Richter; Pankaj Gupta
Journal:  Support Care Cancer       Date:  2018-02-02       Impact factor: 3.603

5.  Hospice caregivers' experiences with pain management: "I'm not a doctor, and I don't know if I helped her go faster or slower".

Authors:  Debra Parker Oliver; Elaine Wittenberg-Lyles; Karla Washington; Robin L Kruse; David L Albright; Paula K Baldwin; Amy Boxer; George Demiris
Journal:  J Pain Symptom Manage       Date:  2013-05-31       Impact factor: 3.612

6.  Fear of analgesic side effects predicts preference for acupuncture: a cross-sectional study of cancer patients with pain in the USA.

Authors:  Kevin T Liou; Kelly M Trevino; Salimah H Meghani; Q Susan Li; Gary Deng; Deborah Korenstein; Jun J Mao
Journal:  Support Care Cancer       Date:  2020-05-08       Impact factor: 3.603

7.  Cancer pain self-management in the context of a national opioid epidemic: Experiences of patients with advanced cancer using opioids.

Authors:  Desiree R Azizoddin; Robert Knoerl; Rosalind Adam; Daniela Kessler; James A Tulsky; Robert R Edwards; Andrea C Enzinger
Journal:  Cancer       Date:  2021-04-27       Impact factor: 6.921

8.  Challenges on the provision of palliative care for patients with cancer in low- and middle-income countries: a systematic review of reviews.

Authors:  Hammoda Abu-Odah; Alex Molassiotis; Justina Liu
Journal:  BMC Palliat Care       Date:  2020-04-22       Impact factor: 3.234

9.  "No thanks, I don't want to see snakes again": a qualitative study of pain management versus preservation of cognition in palliative care patients.

Authors:  Pete Wegier; Jaymie Varenbut; Mark Bernstein; Peter G Lawlor; Sarina R Isenberg
Journal:  BMC Palliat Care       Date:  2020-11-29       Impact factor: 3.234

10.  US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life.

Authors:  Andrea C Enzinger; Kaushik Ghosh; Nancy L Keating; David M Cutler; Mary Beth Landrum; Alexi A Wright
Journal:  J Clin Oncol       Date:  2021-07-22       Impact factor: 50.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.